Download your Whitepaper
Download your whitepaper
A pharmaceutical client was at risk of a product recall due to a capping problem with a new tablet formulation. Visual inspection at the packaging had identified that capped/laminated tablets had made it through to the packaging stage despite the tablets having met intermediate quality inspection.